4.3 Article

Ketamine inhibits LPS-mediated BV2 microglial inflammation via NMDA receptor blockage

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pathology

Ketamine inhibits colorectal cancer cells malignant potential via blockage of NMDA receptor

Wenming Duan et al.

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)

Article Pharmacology & Pharmacy

Propofol attenuates BV2 microglia inflammation via NMDA receptor inhibition

Qichao Wu et al.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2018)

Article Chemistry, Medicinal

Ketamine ameliorates oxidative stress-induced apoptosis in experimental traumatic brain injury via the Nrf2 pathway

Jinwei Liang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2018)

Article Multidisciplinary Sciences

General Anesthetics Inhibit LPS-Induced IL-1β Expression in Glial Cells

Tomoharu Tanaka et al.

PLOS ONE (2013)

Article Cell Biology

Inhibitory Effects of Ketamine on Lipopolysaccharide-Induced Microglial Activation

Yi Chang et al.

MEDIATORS OF INFLAMMATION (2009)

Review Pharmacology & Pharmacy

The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery

Garima Dutta et al.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)

Review Neurosciences

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Michelle L. Block et al.

NATURE REVIEWS NEUROSCIENCE (2007)

Review Pharmacology & Pharmacy

Ca2+/CaM-dependent kinases: From activation to function

SS Hook et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)

Review Biochemistry & Molecular Biology

Propofol in anesthesia. mechanism of action, structure-activity relationships, and drug delivery

G Trapani et al.

CURRENT MEDICINAL CHEMISTRY (2000)